Submitted by Anonymous (not verified) on 25 August 2023 - 11:25
Human medicines European public assessment report (EPAR): Aquipta, atogepant, Migraine Disorders, Date of authorisation: 11/08/2023, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aquipta, atogepant, Migraine Disorders, Date of authorisation: 11/08/2023, Status: Authorised